Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · C41E258302250302144
Glutathione Liposomal 1000 mg très Haute Concentration – 90 Capsules avec Vitamine C, AHA & Acide Alpha-Lipoïque, Origine Angleterre
longtail
3P
MEDICAMENTS
Last 4 weeks demand
3
≈ stable (0.0% vs prev 4w)
Offer Stock
4
Σ Stock across 1 live offer (1P + 3P) · 2026-10-14
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-10-14 snapshot
Unit price
MAD 364
avg of last 30 sells · latest 2026-10-08
C41E258302250302144
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-10-12 · Total forecast: 55 units.
Actual
Realistic forecast (p50)
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Glutathione Liposomal 1000 mg très Haute Concentration – 90 Capsules avec Vitamine C, AHA & Acide Alpha-Lipoïque, Origine Angleterre · in the longtail cohort · last 4 weeks 3 units, stable demand · on-hand 4 units
Signals the model saw
- Cohort: longtail (224 days of history, — units sold over 52 weeks)
- Volatility (CV): 0.53 — moderate
- Recent trend: last 4w = 3 units · prev 4w = 3 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 0.3 units |
| Realistic forecast — next 4 weeks | 3.2 units |
| Realistic forecast — next 3 months | 8.7 units |
| Planning level (p75) — next 4 weeks the order-sizing basis; demand exceeds it ~1 week in 4 | 4.9 units |
| Optimistic — next week | 3.0 units |
| Optimistic — next 4 weeks (reorder target) | 13.5 units |
| Optimistic — next 3 months (quarterly PO target) | 55.2 units |
| Legacy μ/wk (reorder pipeline) | 1.1 |
| Revenue exposure — optimistic, 3 months | MAD 20.1K |